II. Pathophysiology
- Focal arterial spasm of a major Coronary Artery
- Typically in the absence of high grade Coronary Artery stenosis
- Mechanisms
- Vascular Smooth Muscle hyperreactivity to Vasoconstrictors
- Increased vagal tone
- Increased hyperreactivity to sympathetic stimulation
- Endothelial dysfunction
- Comorbid arterial stenosis
- May be associated with other vasospastic conditions
III. Epidemiology
- Age
- More common under age 50 years old
- Race
- More common in Japanese patients than in Caucasian
-
Incidence
- Coronary Artery Vasospasm found in 4% of Coronary Artery angiograms in U.S.
- United States however has among lowest Incidence of Coronary Artery Vasospasm
- Coronary Artery Vasospasm found in 4% of Coronary Artery angiograms in U.S.
IV. Risk Factors
V. Symptoms
- Recurrent episodic Chest Pain consistent with Angina
- Anterior chest discomfort or pressure
- Radiates to neck, jaw, arms as with typical Angina
- Triggers
- Typically occurs at rest without provocation (e.g. without Exercise, not modified by position)
- May be triggered by Hyperventilation, Cocaine, hypersympathetic states (e.g. peak Exercise)
- Timing
- Early morning hours after midnight
- Duration
- Episodes last 5 to 15 minutes
- Characteristics
- Gradual onset and resolution
- Associated symptoms
VI. Labs
- Obtain typical labs for chest Pain Evaluation
- Serial Troponin
- Magnesium
VII. Diagnostics
-
Electrocardiogram
- Normal between episodes
- ST Segment Elevation during vasospastic episode
-
Holter Monitor
- May detect episodes of periodic ST Elevation
- Stress Testing
- Evaluate for severe fixed cardiovascular disease
-
Coronary Angiography
- Consider in most patients with suspected Variant Angina
VIII. Differential Diagnosis
- ST Elevation Myocardial Infarction (STEMI)
- Unstable Angina
- Microvascular Angina
- Acute Pericarditis
- Stress-Induced Cardiomyopathy (Takotsuba Cardiomyopathy)
IX. Management: Prevention of vasospasm
- First-Line measures
- Tobacco Cessation
- Calcium Channel Blockers
- Diltiazem 240 to 360 mg orally daily
- Nifedipine
- Verapamil
- Other measures as indicated
- Statins (e.g. Atorvastatin, Simvastatin, Fluvastatin)
- Replace Magnesium in Magnesium Deficiency
- Second-Line measures
- Long-Acting Nitroglycerin
- Isosorbide Mononitrate 30-60 mg once daily
- Indicated if refractory to Calcium Channel Blockers
- Risk of nitrate tolerance (Calcium Channel Blockers are preferred)
- Long-Acting Nitroglycerin
- Third-Line Measures
- Percutaneous Coronary Intervention (PCI)
- May be indicated in moderate fixed coronary obstruction
- Percutaneous Coronary Intervention (PCI)
- Avoid provocative agents
- Limit Aspirin to low dose
- Higher dose may predispose to vasospasm
- Aspirin 81 mg should be prescribed in atherosclerotic cardiovascular disease
- Avoid non-selective Beta Blockers (e.g. Propranolol)
- Risk of vasospasm
- Avoid other agents associated with vasospasm
- Triptans (e.g. Sumatriptan)
- 5-Fluorouracil
- Limit Aspirin to low dose
X. Complications
-
Myocardial Infarction
- Risk of thrombus forming in response to vasospasm
-
Arrhythmia
- Ventricular Tachycardia (left Coronary Artery)
- Heart Block (right Coronary Artery)
- May present with Syncope to Cardiac Arrest
- Consider Implantable Cardioverter-Defibrillator (ICD)
XI. Resources
- EMedicine Coronary Artery Vasospasm
XII. References
- Pinto, Beltrame, Crea in Saperia (2015) Variant Angina, UpToDate, Wolters Kluwer (accessed 6/13/2015)